Sachetta’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Sachetta’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-225	Closed	-$22.5K	–	1114
2025 Q3	$22.5K	Hold	225	–	–	0.01%	345
2025 Q2	$18.7K	Hold	225	–	–	0.01%	360
2025 Q1	$18.2K	Buy	225 +95	+73%	+$8.49K	0.01%	356
2024 Q4	$11.7K	Hold	130	–	–	﹤0.01%	423
2024 Q3	$12.8K	Hold	130	–	–	0.01%	426
2024 Q2	$12.9K	Hold	130	–	–	0.01%	396
2024 Q1	$11.6K	Hold	130	–	–	0.01%	386
2023 Q4	$11.6K	Buy	+130	New	+$9.65K	0.01%	386

Other funds holding XBI

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return

Sachetta's XBI Position: Q4 2025 in Review

Sachetta sold out of State Street SPDR S&P Biotech ETF (XBI) in Q4 2025, closing a stake of 225 shares — an estimated $22.5K sold.

Sachetta first reported a position in XBI in Q4 2023 and held it in 8 quarters. The position peaked at $22.5K in Q3 2025. 814 funds tracked by Wall St. Rank hold XBI as of Q4 2025.

Sachetta reported no remaining State Street SPDR S&P Biotech ETF position as of Q4 2025 after selling out during the quarter.
Sachetta sold 225 State Street SPDR S&P Biotech ETF shares in Q4 2025, an estimated $22.5K.
Sachetta first reported a position in State Street SPDR S&P Biotech ETF in Q4 2023 and held it in 8 quarters.
Sachetta's State Street SPDR S&P Biotech ETF position peaked at $22.5K in Q3 2025.
814 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q4 2025.

Based on Sachetta's 13F filing for Q4 2025, filed 2 Feb 2026.